|
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer |
|
|
|
Titel: |
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer |
Auteur: |
Matsubara, Yuki Masuishi, Toshiki Ogata, Takatsugu Nakazawa, Taiko Kato, Kyoko Nozawa, Kazuki Narita, Yukiya Honda, Kazunori Bando, Hideaki Taniguchi, Hiroya Kadowaki, Shigenori Ando, Masashi Tajika, Masahiro Muro, Kei |
Verschenen in: |
Journal of cancer research and clinical oncology |
Paginering: |
Jaargang 149 () nr. 3 pagina's 1123-1129 |
Jaar: |
2022-03-22 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|